National Institute of Neurological Disorders and Stroke; Notice of Meetings, 72980-72981 [2015-29729]
Download as PDF
<![CDATA[
wgreen on DSK2VPTVN1PROD with NOTICES
72980
Federal Register / Vol. 80, No. 225 / Monday, November 23, 2015 / Notices
notice will be posted on the NTP Web
site, and the submitter will be identified
by name, affiliation, and/or sponsoring
organization.
Public comment at this meeting is
welcome, with time set aside for the
presentation of oral comments on the
draft TRs. In addition to in-person oral
comments at the NIEHS, public
comments can be presented by
teleconference line. There will be 50
lines for this call; availability is on a
first-come, first-served basis. The lines
will be open from 9:00 a.m. until
approximately 4:00 p.m. EDT on
February 16, 2016, although oral
comments will be received only during
the formal public comment periods
indicated on the preliminary agenda.
The access number for the
teleconference line will be provided to
registrants by email prior to the meeting.
Each organization is allowed one time
slot for each draft TR. At least 7 minutes
will be allotted to each time slot, and if
time permits, may be extended to 10
minutes at the discretion of the chair.
Persons wishing to make an oral
presentation are asked to register online
at https://ntp.niehs.nih.gov/go/36051 by
February 9, 2016, indicate whether they
will present comments in-person or via
the teleconference line. If possible, oral
public commenters should send a copy
of their slides and/or statement or
talking points at that time. Written
statements can supplement and may
expand the oral presentation.
Registration for in-person oral
comments will also be available at the
meeting, although time allowed for
presentation by on-site registrants may
be less than that for registered speakers
and will be determined by the number
of speakers who register on-site.
Background Information on NTP Peer
Review Panels: NTP panels are
technical, scientific advisory bodies
established on an ‘‘as needed’’ basis to
provide independent scientific peer
review and advise the NTP on agents of
public health concern, new/revised
toxicological test methods, or other
issues. These panels help ensure
transparent, unbiased, and scientifically
rigorous input to the program for its use
in making credible decisions about
human hazard, setting research and
testing priorities, and providing
information to regulatory agencies about
alternative methods for toxicity
screening. The NTP welcomes
nominations of scientific experts for
upcoming panels. Scientists interested
in serving on an NTP panel should
provide current curriculum vitae to the
FOR FURTHER INFORMATION CONTACT. The
authority for NTP panels is provided by
42 U.S.C. 217a; section 222 of the Public
VerDate Sep<11>2014
14:25 Nov 20, 2015
Jkt 238001
Health Service (PHS) Act, as amended.
The panel is governed by the Federal
Advisory Committee Act, as amended (5
U.S.C. Appendix 2), which sets forth
standards for the formation and use of
advisory committees.
Dated: November 17, 2015.
John R. Bucher,
Associate Director, NTP.
[FR Doc. 2015–29733 Filed 11–20–15; 8:45 am]
BILLING CODE 4140–01–P
Contact Person: Najma Begum, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 749, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–8894,
begumn@niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: November 17, 2015.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
National Institutes of Health
[FR Doc. 2015–29739 Filed 11–20–15; 8:45 am]
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; PAR–14–301:
NIDDK Central Repositories Sample Access
from Clinical Trials (X01).
Date: February 1, 2016.
Time: 11:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Najma Begum, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 749, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–8894,
begumn@niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; RFA–DK–15–017:
Adherence Studies in Adolescents with CKD
or Urological Diseases (R01).
Date: February 8, 2016.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the National Advisory
Neurological Disorders and Stroke
Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Neurological Disorders and Stroke Council.
Date: February 4–5, 2016.
Open: February 4, 2016, 8:00 a.m. to 3:30
p.m.
Agenda: Report by the Director, NINDS;
Report by the Director, Division of
Extramural Research; and Administrative and
Program Developments.
Place: National Institutes of Health,
Building 31, C Wing, Conference Room 10,
31 Center Drive, Bethesda, MD 20892.
E:\FR\FM\23NON1.SGM
23NON1
Federal Register / Vol. 80, No. 225 / Monday, November 23, 2015 / Notices
Closed: February 4, 2016, 3:30 p.m. to 5:00
p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, C Wing, Conference Room 10,
31 Center Drive, Bethesda, MD 20892.
Closed: February 5, 2016, 8:00 a.m. to
11:00 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, C Wing, Conference Room 10,
31 Center Drive, Bethesda, MD 20892.
Contact Person: Robert Finkelstein, Ph.D.,
Director, Division of Extramural Research,
National Institute of Neurological Disorders
and Stroke, NIH, 6001 Executive Blvd., Suite
3309, MSC 9531, Bethesda, MD 20892, (301)
496–9248.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: https://
www.ninds.nih.gov, where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS).
Dated: November 17, 2015.
Sylvia Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–29729 Filed 11–20–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
[Docket ID FEMA–2014–0022]
wgreen on DSK2VPTVN1PROD with NOTICES
Technical Mapping Advisory Council;
Meeting
Federal Emergency
Management Agency, DHS
ACTION: Committee management; Notice
of Federal advisory committee meeting.
AGENCY:
The Federal Emergency
Management Agency (FEMA) Technical
SUMMARY:
VerDate Sep<11>2014
14:25 Nov 20, 2015
Jkt 238001
Mapping Advisory Council (TMAC) will
meet via conference call on December 9
and 10, 2015. The meeting will be open
to the public.
DATES: The TMAC will meet via
conference call on Wednesday,
December 9 from 10:00 a.m. to 5:30 p.m.
Eastern Standard Time (EST), and on
Thursday, December 10, 2015 from
10:00 a.m. to 4:30 p.m. EST. Please note
that the meeting will close early if the
TMAC has completed its business.
ADDRESSES: For information on how to
access to the conference call,
information on services for individuals
with disabilities, or to request special
assistance for the meeting, contact the
person listed in FOR FURTHER
INFORMATION CONTACT below as soon as
possible. Members of the public who
wish to dial in for the meeting must
register in advance by sending an email
to FEMA-TMAC@fema.dhs.gov
(attention Mark Crowell) by 11 a.m. EST
on Friday, December 4, 2015.
To facilitate public participation,
members of the public are invited to
provide written comments on the issues
to be considered by the TMAC, as listed
in the SUPPLEMENTARY INFORMATION
section below. The Agenda and other
associated reports and material will be
available for review at www.fema.gov/
TMAC by Wednesday, December 2,
2015. Written comments to be
considered by the committee at the time
of the meeting must be received by
Friday, December 4, 2015, identified by
Docket ID FEMA–2014–0022, and
submitted by one of the following
methods:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
• Email: Address the email TO:
FEMA-RULES@fema.dhs.gov and CC:
FEMA-TMAC@fema.dhs.gov. Include
the docket number in the subject line of
the message. Include name and contact
detail in the body of the email.
• Mail: Regulatory Affairs Division,
Office of Chief Counsel, FEMA, 500 C
Street SW., Room 8NE, Washington, DC
20472–3100.
Instructions: All submissions received
must include the words ‘‘Federal
Emergency Management Agency’’ and
the docket number for this action.
Comments received will be posted
without alteration at https://
www.regulations.gov, including any
personal information provided. Docket:
For docket access to read background
documents or comments received by the
TMAC, go to https://www.regulations.gov
and search for the Docket ID FEMA–
2014–0022.
A public comment period will be held
on December 9, 2015, from 11:00–11:20
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
72981
a.m. and December 10, 2015 from
11:00–11:20 a.m. EST. Speakers are
requested to limit their comments to no
more than two minutes. Each public
comment period will not exceed 20
minutes. Please note that the public
comment periods may end before the
time indicated, following the last call
for comments. Contact the individual
listed below to register as a speaker by
close of business on Friday, December 4,
2015.
FOR FURTHER INFORMATION CONTACT:
Mark Crowell, Designated Federal
Officer for the TMAC, FEMA, 1800
South Bell Street Arlington, VA 22202,
telephone (202) 646–3432, and email
mark.crowell@fema.dhs.gov. The TMAC
Web site is: https://www.fema.gov/
TMAC.
SUPPLEMENTARY INFORMATION: Notice of
this meeting is given under the Federal
Advisory Committee Act, 5 U.S.C.
Appendix.
As required by the Biggert-Waters
Flood Insurance Reform Act of 2012, the
TMAC makes recommendations to the
FEMA Administrator on: (1) How to
improve, in a cost-effective manner, the
(a) accuracy, general quality, ease of use,
and distribution and dissemination of
flood insurance rate maps and risk data;
and (b) performance metrics and
milestones required to effectively and
efficiently map flood risk areas in the
United States; (2) mapping standards
and guidelines for (a) flood insurance
rate maps, and (b) data accuracy, data
quality, data currency, and data
eligibility; (3) how to maintain, on an
ongoing basis, flood insurance rate maps
and flood risk identification; (4)
procedures for delegating mapping
activities to State and local mapping
partners; and (5)(a) methods for
improving interagency and
intergovernmental coordination on
flood mapping and flood risk
determination, and (b) a funding
strategy to leverage and coordinate
budgets and expenditures across Federal
agencies. Furthermore, the TMAC is
required to submit an Annual Report to
the FEMA Administrator that contains:
(1) a description of the activities of the
Council; (2) an evaluation of the status
and performance of flood insurance rate
maps and mapping activities to revise
and update Flood Insurance Rate Maps;
and (3) a summary of recommendations
made by the Council to the FEMA
Administrator.
The TMAC must also develop
recommendations on how to ensure that
flood insurance rate maps incorporate
the best available climate science to
assess flood risks and ensure that FEMA
uses the best available methodology to
E:\FR\FM\23NON1.SGM
23NON1
]]>Agencies
[Federal Register Volume 80, Number 225 (Monday, November 23, 2015)]
[Notices]
[Pages 72980-72981]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-29729]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke; Notice
of Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the National
Advisory Neurological Disorders and Stroke Council.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable materials, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Neurological Disorders and
Stroke Council.
Date: February 4-5, 2016.
Open: February 4, 2016, 8:00 a.m. to 3:30 p.m.
Agenda: Report by the Director, NINDS; Report by the Director,
Division of Extramural Research; and Administrative and Program
Developments.
Place: National Institutes of Health, Building 31, C Wing,
Conference Room 10, 31 Center Drive, Bethesda, MD 20892.
[[Page 72981]]
Closed: February 4, 2016, 3:30 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Building 31, C Wing,
Conference Room 10, 31 Center Drive, Bethesda, MD 20892.
Closed: February 5, 2016, 8:00 a.m. to 11:00 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Building 31, C Wing,
Conference Room 10, 31 Center Drive, Bethesda, MD 20892.
Contact Person: Robert Finkelstein, Ph.D., Director, Division of
Extramural Research, National Institute of Neurological Disorders
and Stroke, NIH, 6001 Executive Blvd., Suite 3309, MSC 9531,
Bethesda, MD 20892, (301) 496-9248.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
Information is also available on the Institute's/Center's home
page: https://www.ninds.nih.gov, where an agenda and any additional
information for the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.853,
Clinical Research Related to Neurological Disorders; 93.854,
Biological Basis Research in the Neurosciences, National Institutes
of Health, HHS).
Dated: November 17, 2015.
Sylvia Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-29729 Filed 11-20-15; 8:45 am]
BILLING CODE 4140-01-P
